Switch to:
GuruFocus has detected 2 Warning Signs with NovaBay Pharmaceuticals Inc $NBY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
NovaBay Pharmaceuticals Inc (AMEX:NBY)
EV-to-EBITDA
-3.41 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, NovaBay Pharmaceuticals Inc's enterprise value is $34.24 Mil. NovaBay Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $-10.04 Mil. Therefore, NovaBay Pharmaceuticals Inc's EV/EBITDA ratio for today is -3.41.

NBY' s EV-to-EBITDA Range Over the Past 10 Years
Min: -59.6   Max: 46
Current: -3.42

-59.6
46

During the past 13 years, the highest EV/EBITDA Ratio of NovaBay Pharmaceuticals Inc was 46.00. The lowest was -59.60. And the median was -3.10.

NBY's EV-to-EBITDA is ranked lower than
99.99% of the 466 Companies
in the Global Biotechnology industry.

( Industry Median: 17.12 vs. NBY: -3.42 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, NovaBay Pharmaceuticals Inc's stock price is $2.75. NovaBay Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.82. Therefore, NovaBay Pharmaceuticals Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

NovaBay Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=34.242/-10.043
=-3.41

NovaBay Pharmaceuticals Inc's current Enterprise Value is $34.24 Mil.
NovaBay Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was -2.178 (Jun. 2016 ) + -1.982 (Sep. 2016 ) + -2.124 (Dec. 2016 ) + -3.759 (Mar. 2017 ) = $-10.04 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

NovaBay Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=2.75/-0.82
=

NovaBay Pharmaceuticals Inc's share price for today is $2.75.
NovaBay Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was -0.36 (Jun. 2016 ) + -0.34 (Sep. 2016 ) + 0.14 (Dec. 2016 ) + -0.26 (Mar. 2017 ) = $-0.82.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

NovaBay Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda -10.25-1.2511.87-6.43-6.17-3.13-2.75-1.63-0.30-3.75

NovaBay Pharmaceuticals Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda -1.63-2.11-2.09-0.93-0.30-0.59-1.09-3.44-3.750.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK